main-image-rodin-FPO

Rodin Therapeutics

Rodin Therapeutics is targeting epigenetics, or changes in gene expression, to develop therapeutics for cognitive impairment in Alzheimer’s disease and other neurological disorders.

Headquarters Cambridge, MA
Website www.rodintherapeutics.com​
Pipeline Preclinical